After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the commercial rollout is gaining traction.
EZZ Life Science Holdings has struck a strategic cooperation framework with JD Health, marking a further push into China’s rapidly expanding health and wellness market.